Stay updated on Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial
Sign up to get notified when there's something new on the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page.

Latest updates to the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedAdded Small Cell Lung Carcinoma and Acute Myeloid Leukemia to the study conditions and introduced the Genetic and Rare Diseases Information Center as a new resources entry.SummaryDifference0.1%

- Check23 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No study details or user-facing content appear to have changed.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page now displays Revision: v3.4.2, updating from Revision: v3.4.1.SummaryDifference0.0%

- Check66 days agoChange DetectedThe only change is a revision update from v3.4.0 to v3.4.1; there are no modifications to the study details or related content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no changes to study content or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page.